Status:
COMPLETED
Oral Bioavailability of Two Solid Formulations of GLPG0634
Lead Sponsor:
Galapagos NV
Conditions:
Healthy
Eligibility:
MALE
40-60 years
Phase:
PHASE1
Brief Summary
The purpose of the study is to evaluate the amount of compound present in the blood (relative bioavailability) after a single administration of GLPG0634 as a tablet versus a capsule in fasted conditio...
Eligibility Criteria
Inclusion
- Healthy male, age 40-60 years
- BMI between 18-30 kg/m2
Exclusion
- Any condition that might interfere with the procedures or tests in this study
- Drug or alcohol abuse
- Smoking
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01915667
Start Date
July 1 2013
End Date
September 1 2013
Last Update
September 17 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SGS LSS Clinical Pharmacology Unit Antwerp
Antwerp, Antwerp, Belgium